| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Common Stock | Award | $0 | +43.1K | +1.59% | $0.00 | 2.75M | Jun 28, 2024 | Direct | F1, F2 |
| holding | LAB | Common Stock | 13.9M | Jun 28, 2024 | Casdin Private Growth Equity Fund II, L.P. | F3 | |||||
| holding | LAB | Common Stock | 2.74M | Jun 28, 2024 | By Casdin Private Growth Equity Fund, L.P. | F4 | |||||
| holding | LAB | Common Stock | 18.9K | Jun 28, 2024 | See footnote | F5 | |||||
| holding | LAB | Common Stock | 46.7M | Jun 28, 2024 | Casdin Partners Master Fund, L.P | F6 | |||||
| holding | LAB | Common Stock | 545K | Jun 28, 2024 | Casdin Amplify Fund, LP | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LAB | Stock Option (Right to buy) | Award | $0 | +72.2K | $0.00 | 72.2K | Jun 28, 2024 | Common Stock | 72.2K | $1.77 | Direct | F8 |
| Id | Content |
|---|---|
| F1 | Represents Restricted Stock Units ("RSUs") that vest in full on the earlier to occur of June 28, 2025 and one day prior to the date of the Company's next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. |
| F2 | Includes 2,604,060 shares of common stock received in a pro rata distribution for no consideration by C-LSH II LLC in accordance with the exemptions afforded by Rule 16a-9 of the Securities Exchange Act of 1934, as amended. |
| F3 | The securities are owned directly by Casdin Private Growth Equity Fund II, L.P. (the "Equity Fund II") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC ("Casdin"), the investment adviser to the Equity Fund II, and (ii) Eli Casdin, the managing member of Casdin. |
| F4 | The securities are owned directly by Casdin Private Growth Equity Fund, L.P. (the "Equity Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Equity Fund, and (ii) Eli Casdin, the managing member of Casdin. |
| F5 | The securities are indirectly owned by Eli Casdin who has voting and investment discretion with respect to the securities. |
| F6 | The securities are owned directly by Casdin Partners Master Fund, L.P. (the "Master Fund") and may be deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP. |
| F7 | The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and are deemed to be indirectly beneficially owned by (i) Casdin, the investment adviser to Amplify, (ii) the GP, the general partner of Amplify, and (iii) Eli Casdin, the managing member of Casdin and the GP. |
| F8 | The Option becomes exercisable in twelve equal monthly installments beginning on July 28, 2024, subject to the Reporting Person's continued service through the applicable vesting date. |
The Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.